Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, USA.
Nature. 2009 Nov 26;462(7272):461-4. doi: 10.1038/nature08605.
The promise of point-of-care medical diagnostics - tests that can be carried out at the site of patient care - is enormous, bringing the benefits of fast and reliable testing and allowing rapid decisions on the course of treatment to be made. To this end, much innovation is occurring in technologies for use in biodiagnostic tests. Assays based on nanomaterials, for example, are now beginning to make the transition from the laboratory to the clinic. But the potential for such assays to become part of routine medical testing depends on many scientific factors, including sensitivity, selectivity and versatility, as well as technological, financial and policy factors.
即时医疗诊断的前景非常广阔——这些测试可以在病人护理现场进行,为快速、可靠的检测带来益处,并能够迅速做出治疗方案的决策。为此,生物诊断测试技术正在进行大量创新。例如,基于纳米材料的检测方法已开始从实验室向临床应用过渡。但是,此类检测要成为常规医疗检测的一部分,还取决于许多科学因素,包括灵敏度、选择性和多功能性,以及技术、财务和政策因素。